CD274 and central nervous system cancer: Inhibition of TLX expression significantly inhibited tumor growth and promoted antitumor immune responses by decreasing PD‐L1 expression, glioma‐associated macrophage numbers, and increasing cytotoxic lymphocyte infiltration.